• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Red ginseng for treating erectile dysfunction: a systematic review.红参治疗勃起功能障碍:一项系统评价
Br J Clin Pharmacol. 2008 Oct;66(4):444-50. doi: 10.1111/j.1365-2125.2008.03236.x. Epub 2008 Jun 9.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea.无创正压通气治疗阻塞性睡眠呼吸暂停男性勃起功能障碍。
Cochrane Database Syst Rev. 2021 Sep 23;9(9):CD013169. doi: 10.1002/14651858.CD013169.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
8
Kava extract for treating anxiety.用于治疗焦虑症的卡瓦提取物。
Cochrane Database Syst Rev. 2003;2003(1):CD003383. doi: 10.1002/14651858.CD003383.
9
Selective noradrenaline reuptake inhibitors for schizophrenia.用于治疗精神分裂症的选择性去甲肾上腺素再摄取抑制剂。
Cochrane Database Syst Rev. 2018 Jan 25;1(1):CD010219. doi: 10.1002/14651858.CD010219.pub2.
10
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.

引用本文的文献

1
A pharmacokinetic study on red ginseng with furosemide in equine.马中红参与速尿的药代动力学研究。
Front Vet Sci. 2023 Nov 24;10:1319998. doi: 10.3389/fvets.2023.1319998. eCollection 2023.
2
Unlocking Potentially Therapeutic Phytochemicals in Capadulla () from Guyana Using Untargeted Mass Spectrometry-Based Metabolomics.利用非靶向质谱代谢组学揭示来自圭亚那的卡帕杜拉(Capadulla)中潜在的治疗性植物化学物质。
Metabolites. 2023 Oct 3;13(10):1050. doi: 10.3390/metabo13101050.
3
The role of red ginseng in men's reproductive health: a literature review.红参在男性生殖健康中的作用:文献综述
Basic Clin Androl. 2023 Oct 26;33(1):27. doi: 10.1186/s12610-023-00203-0.
4
Ginseng and health outcomes: an umbrella review.人参与健康结局:一项伞状综述
Front Pharmacol. 2023 Jul 3;14:1069268. doi: 10.3389/fphar.2023.1069268. eCollection 2023.
5
Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements.测定膳食补充剂中的磷酸二酯酶-5 抑制剂(PDE-5)
Molecules. 2023 May 16;28(10):4116. doi: 10.3390/molecules28104116.
6
Saponins of ginseng products: a review of their transformation in processing.人参制品中的皂苷:加工过程中其转化的综述
Front Pharmacol. 2023 Apr 28;14:1177819. doi: 10.3389/fphar.2023.1177819. eCollection 2023.
7
Long-term administration of red ginseng non-saponin fraction rescues the loss of skeletal muscle mass and strength associated with aging in mice.长期给予红参非皂苷组分可挽救与小鼠衰老相关的骨骼肌质量和力量的丧失。
J Ginseng Res. 2022 Sep;46(5):657-665. doi: 10.1016/j.jgr.2021.12.001. Epub 2021 Dec 16.
8
Korean Red Ginseng Ameliorates Allergic Asthma through Reduction of Lung Inflammation and Oxidation.韩国红参通过减轻肺部炎症和氧化作用改善过敏性哮喘。
Antioxidants (Basel). 2022 Jul 22;11(8):1422. doi: 10.3390/antiox11081422.
9
Randomized, Triple-Blinded, Placebo-Controlled Trial of SA3X (Spilanthes acmella) for the Management of Erectile Dysfunction.SA3X(金纽扣)治疗勃起功能障碍的随机、三盲、安慰剂对照试验
Cureus. 2022 Apr 9;14(4):e23989. doi: 10.7759/cureus.23989. eCollection 2022 Apr.
10
Hormonal, Histological, and Comparative Study of the Effect of Pure Ginseng on Testicular Function in the Breeding/Non-Breeding Season of Rams in Basrah.对巴斯拉地区公羊繁殖/非繁殖季节中纯人参对睾丸功能影响的激素、组织学和比较研究。
Arch Razi Inst. 2021 Nov 30;76(5):1519-1535. doi: 10.22092/ari.2021.355554.1697. eCollection 2021 Nov.

本文引用的文献

1
Erectile dysfunction.勃起功能障碍
Clin Evid. 2006 Jun(15):1227-51.
2
Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction.韩国红参治疗勃起功能障碍的疗效研究。
Asian J Androl. 2007 Mar;9(2):241-4. doi: 10.1111/j.1745-7262.2007.00210.x. Epub 2006 Jul 11.
3
Nutrients and botanicals for erectile dysfunction: examining the evidence.用于勃起功能障碍的营养物质和植物药:审视相关证据。
Altern Med Rev. 2004 Mar;9(1):4-16.
4
A double-blind crossover study evaluating the efficacy of korean red ginseng in patients with erectile dysfunction: a preliminary report.一项评估韩国红参对勃起功能障碍患者疗效的双盲交叉研究:初步报告。
J Urol. 2002 Nov;168(5):2070-3. doi: 10.1016/S0022-5347(05)64298-X.
5
Panax ginseng: a systematic review of adverse effects and drug interactions.人参:不良反应与药物相互作用的系统评价
Drug Saf. 2002;25(5):323-44. doi: 10.2165/00002018-200225050-00003.
6
Panax ginseng--a non-organ-specific cancer preventive?人参——一种非器官特异性癌症预防剂?
Lancet Oncol. 2001 Jan;2(1):49-55. doi: 10.1016/S1470-2045(00)00196-0.
7
Location bias in controlled clinical trials of complementary/alternative therapies.补充/替代疗法对照临床试验中的位置偏倚。
J Clin Epidemiol. 2000 May;53(5):485-9. doi: 10.1016/s0895-4356(99)00220-6.
8
In vitro and in vivo experimental effect of Korean red ginseng on erection.韩国红参对勃起的体外和体内实验效果
J Urol. 1999 Oct;162(4):1508-11.
9
The relaxation effects of ginseng saponin in rabbit corporal smooth muscle: is it a nitric oxide donor?人参皂苷对兔阴茎海绵体平滑肌的舒张作用:它是一氧化氮供体吗?
Br J Urol. 1998 Nov;82(5):744-8. doi: 10.1046/j.1464-410x.1998.00811.x.
10
A review of 12 commonly used medicinal herbs.对12种常用草药的综述。
Arch Fam Med. 1998 Nov-Dec;7(6):523-36. doi: 10.1001/archfami.7.6.523.

红参治疗勃起功能障碍:一项系统评价

Red ginseng for treating erectile dysfunction: a systematic review.

作者信息

Jang Dai-Ja, Lee Myeong Soo, Shin Byung-Cheul, Lee Young-Cheoul, Ernst Edzard

机构信息

Korea Food Research Institute, Sungnam, South Korea.

出版信息

Br J Clin Pharmacol. 2008 Oct;66(4):444-50. doi: 10.1111/j.1365-2125.2008.03236.x. Epub 2008 Jun 9.

DOI:10.1111/j.1365-2125.2008.03236.x
PMID:18754850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2561113/
Abstract

AIMS

Korean red ginseng (unskinned Panax ginseng before it is steamed or otherwise heated and subsequently dried) is one of the most widely used herbal remedies. This systematic review evaluates the current evidence for the effectiveness of red ginseng for treating erectile dysfunction.

METHODS

Systematic searches were conducted on 20 electronic databases without language restrictions. Hand-searches included conference proceedings and our files. All randomized clinical studies (RCT) of red ginseng as a treatment of erectile dysfunction were considered for inclusion. Methodological quality was assessed using the Jadad score.

RESULTS

Seven RCTs met all the inclusion criteria. Their methodological quality was low on average. Six of the included RCTs compared the therapeutic efficacy of red ginseng with placebo. The meta-analysis of these data showed a significant effect (n = 349, risk ratio, 2.40; 95% CI of 1.65, 3.51, p < 0.00001, heterogeneity: tau(2) = 0.05, chi(2) = 6.42, p = 0.27, I(2) = 22%). Subgroup analyses also showed beneficial effects of red ginseng in psychogenic erectile dysfunction (n = 135, risk ratio, 2.05; 95% CI of 1.33, 3.16, p = 0.001, heterogeneity: chi(2) = 0.08, p = 0.96, I(2) = 0%).

CONCLUSIONS

Collectively these RCTs provide suggestive evidence for the effectiveness of red ginseng in the treatment of erectile dysfunction. However, the total number of RCTs included in the analysis, the total sample size and the methodological quality of the primary studies were too low to draw definitive conclusions. Thus more rigorous studies are necessary.

摘要

目的

高丽参(未去皮的人参,经蒸煮或其他加热方式处理后干燥)是使用最广泛的草药疗法之一。本系统评价评估了高丽参治疗勃起功能障碍有效性的现有证据。

方法

对20个无语言限制的电子数据库进行系统检索。手工检索包括会议论文集和我们的存档资料。纳入所有将高丽参作为勃起功能障碍治疗方法的随机临床研究(RCT)。使用Jadad评分评估方法学质量。

结果

7项RCT符合所有纳入标准。它们的方法学质量平均较低。纳入的RCT中有6项比较了高丽参与安慰剂的治疗效果。对这些数据的荟萃分析显示有显著效果(n = 349,风险比为2.40;95%置信区间为1.65至3.51,p < 0.00001,异质性:tau(2) = 0.05,chi(2) = 6.42,p = 0.27,I(2) = 22%)。亚组分析还显示高丽参对心因性勃起功能障碍有有益效果(n = 135,风险比为2.05;95%置信区间为1.33至3.16,p = 0.001,异质性:chi(2) = 0.08,p = 0.96,I(2) = 0%)。

结论

总体而言,这些RCT为高丽参治疗勃起功能障碍的有效性提供了提示性证据。然而,分析中纳入的RCT总数、总样本量以及原始研究的方法学质量过低,无法得出明确结论。因此需要更严谨的研究。